(-)-alpha-phellandrene increases expression ISO RGD:69125 6480464 alpha phellandrene results in increased expression of ALDOC mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate increases expression ISO RGD:69125 6480464 epigallocatechin gallate results in increased expression of ALDOC protein CTD PMID:31195006 (RS)-coclaurine multiple interactions ISO RGD:10143 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 (RS)-norcoclaurine multiple interactions ISO RGD:10143 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 (S)-coclaurine multiple interactions ISO RGD:10143 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 1,10-phenanthroline increases expression ISO RGD:69125 6480464 1, 10-phenanthroline results in increased expression of ALDOC mRNA CTD PMID:19502547 1,2-dimethylhydrazine decreases expression ISO RGD:10143 6480464 1 more ... CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ALDOC mRNA CTD PMID:12655037 17alpha-ethynylestradiol multiple interactions ISO RGD:10143 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOA mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOC mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:10143 6480464 Ethinyl Estradiol results in increased expression of ALDOA mRNA, Ethinyl Estradiol results in increased expression of ALDOC mRNA CTD PMID:17942748 , PMID:19400957 17beta-estradiol decreases expression ISO RGD:69125 6480464 Estradiol results in decreased expression of ALDOC mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:10143 6480464 Estradiol results in increased expression of ALDOA mRNA CTD PMID:15289156 17beta-estradiol decreases expression ISO RGD:10143 6480464 Estradiol results in decreased expression of ALDOA mRNA CTD PMID:19484750 1H-pyrazole decreases expression ISO RGD:10143 6480464 pyrazole results in decreased expression of ALDOC mRNA CTD PMID:17945193 1H-pyrazole increases expression ISO RGD:10143 6480464 pyrazole results in increased expression of ALDOA mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10143 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10143 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOA mRNA more ... CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDOC mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69125 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALDOC mRNA CTD PMID:20106945 , PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10143 6480464 Tetrachlorodibenzodioxin affects the expression of ALDOA mRNA, Tetrachlorodibenzodioxin affects the expression of ALDOC mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10143 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALDOA mRNA, Tetrachlorodibenzodioxin results in decreased expression of ALDOC mRNA CTD PMID:15667827 , PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10143 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDOA mRNA, Tetrachlorodibenzodioxin results in increased expression of ALDOC mRNA CTD PMID:16922920 , PMID:19770486 2,4,6-tribromophenol decreases expression ISO RGD:69125 6480464 2 more ... CTD PMID:31675489 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP 6480464 2 more ... CTD PMID:19954255 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10143 6480464 tetrabromobisphenol A results in decreased expression of ALDOC mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10143 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ALDOA mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69125 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALDOC mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69125 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALDOC mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:69125 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ALDOC protein CTD PMID:34186270 4-hydroxynon-2-enal multiple interactions ISO RGD:10143 6480464 Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein] CTD PMID:20889679 4-hydroxyphenyl retinamide increases expression ISO RGD:69125 6480464 Fenretinide results in increased expression of ALDOC mRNA CTD PMID:16671099 4-hydroxyphenyl retinamide increases expression ISO RGD:10143 6480464 Fenretinide results in increased expression of ALDOC mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:69125 6480464 Decitabine results in increased expression of ALDOC mRNA CTD PMID:17908484 aconitine increases expression EXP 6480464 Aconitine results in increased expression of ALDOC protein CTD PMID:33236894 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of ALDOC mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:69125 6480464 Acrylamide results in decreased expression of ALDOC mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:10143 6480464 Aflatoxin B1 results in decreased expression of ALDOC mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:69125 6480464 Aflatoxin B1 results in decreased expression of ALDOC mRNA CTD PMID:27153756 aldrin decreases expression ISO RGD:10143 6480464 Aldrin results in decreased expression of ALDOA mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:69125 6480464 Tretinoin results in increased expression of ALDOC mRNA, Tretinoin results in increased expression of ALDOC protein CTD PMID:15894607 , PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:69125 6480464 Tretinoin results in decreased expression of ALDOC mRNA CTD PMID:23724009 alpha-phellandrene increases expression ISO RGD:69125 6480464 alpha phellandrene results in increased expression of ALDOC mRNA CTD PMID:25075043 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALDOC mRNA CTD PMID:16483693 Archazolid B increases expression ISO RGD:69125 6480464 archazolid B results in increased expression of ALDOC mRNA CTD PMID:25218289 aristolochic acid A increases expression ISO RGD:69125 6480464 aristolochic acid I results in increased expression of ALDOC mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:10143 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ALDOA mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:69125 6480464 Arsenic Trioxide results in decreased expression of ALDOC mRNA CTD PMID:15725085 arsenous acid multiple interactions ISO RGD:69125 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDOC protein] CTD PMID:26598702 atrazine increases expression ISO RGD:69125 6480464 Atrazine results in increased expression of ALDOC mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:10143 6480464 Benzo(a)pyrene results in decreased expression of ALDOC mRNA CTD PMID:19770486 benzo[a]pyrene affects expression ISO RGD:10143 6480464 Benzo(a)pyrene affects the expression of ALDOA mRNA CTD PMID:22342234 benzo[a]pyrene increases methylation ISO RGD:69125 6480464 Benzo(a)pyrene results in increased methylation of ALDOC promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:69125 6480464 7 more ... CTD PMID:19150397 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ALDOC mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ALDOC mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:10143 6480464 bisphenol A results in increased expression of ALDOC mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:69125 6480464 bisphenol A results in decreased expression of ALDOC protein CTD PMID:31675489 bisphenol A increases methylation ISO RGD:10143 6480464 bisphenol A results in increased methylation of ALDOA promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:10143 6480464 bisphenol A results in decreased expression of ALDOA protein CTD PMID:35999755 bisphenol A affects expression ISO RGD:69125 6480464 bisphenol A affects the expression of ALDOC mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:69125 6480464 bisphenol A results in increased expression of ALDOC mRNA, bisphenol A results in increased expression of ALDOC protein CTD PMID:29275510 , PMID:34186270 Bisphenol B increases expression ISO RGD:69125 6480464 bisphenol B results in increased expression of ALDOC protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:69125 6480464 bisphenol F results in increased expression of ALDOC protein CTD PMID:34186270 bleomycin A2 multiple interactions ISO RGD:10143 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 butan-1-ol multiple interactions ISO RGD:69125 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDOC mRNA CTD PMID:29432896 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 cadmium dichloride increases expression ISO RGD:10143 6480464 Cadmium Chloride results in increased expression of ALDOC mRNA CTD PMID:29408670 caffeine multiple interactions ISO RGD:10143 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 caffeine affects phosphorylation ISO RGD:69125 6480464 Caffeine affects the phosphorylation of ALDOC protein CTD PMID:35688186 cannabidiol increases expression ISO RGD:10143 6480464 Cannabidiol results in increased expression of ALDOA mRNA CTD PMID:31052254 cannabidiol decreases expression ISO RGD:69125 6480464 Cannabidiol results in decreased expression of ALDOC protein CTD PMID:34122009 captan increases expression ISO RGD:10143 6480464 Captan results in increased expression of ALDOA mRNA, Captan results in increased expression of ALDOC mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:10143 6480464 Nanotubes, Carbon analog results in increased expression of ALDOC mRNA CTD PMID:25554681 carbon nanotube affects expression ISO RGD:10143 6480464 Nanotubes, Carbon affects the expression of ALDOA protein CTD PMID:21135415 carbon nanotube decreases expression ISO RGD:10143 6480464 Nanotubes, Carbon results in decreased expression of ALDOC mRNA CTD PMID:25620056 celecoxib affects expression ISO RGD:10143 6480464 Celecoxib affects the expression of ALDOC mRNA CTD PMID:20562220 cisplatin increases expression ISO RGD:69125 6480464 Cisplatin results in increased expression of ALDOC mRNA CTD PMID:27594783 cisplatin affects expression ISO RGD:10143 6480464 Cisplatin affects the expression of ALDOA mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:10143 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 cisplatin multiple interactions ISO RGD:69125 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of ALDOC mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of ALDOC mRNA] CTD PMID:27392435 cisplatin decreases expression ISO RGD:10143 6480464 Cisplatin results in decreased expression of ALDOC mRNA CTD PMID:24280081 cisplatin decreases expression ISO RGD:69125 6480464 Cisplatin results in decreased expression of ALDOC mRNA CTD PMID:24280081 clozapine decreases expression ISO RGD:10143 6480464 Clozapine results in decreased expression of ALDOC mRNA CTD PMID:16465460 clozapine increases expression EXP 6480464 Clozapine results in increased expression of ALDOC mRNA CTD PMID:15860345 cobalt dichloride increases expression ISO RGD:69125 6480464 cobaltous chloride results in increased expression of ALDOC mRNA CTD PMID:22202117 , PMID:24486526 cobalt dichloride multiple interactions ISO RGD:69125 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] CTD PMID:22202117 copper(II) chloride decreases expression ISO RGD:10143 6480464 cupric chloride results in decreased expression of ALDOC protein CTD PMID:29617964 copper(II) chloride increases expression ISO RGD:10143 6480464 cupric chloride results in increased expression of ALDOA protein CTD PMID:29617964 CU-O LINKAGE decreases expression ISO RGD:69125 6480464 cupric oxide results in decreased expression of ALDOC protein CTD PMID:25470785 curcumin decreases expression ISO RGD:69125 6480464 Curcumin results in decreased expression of ALDOC mRNA CTD PMID:17198877 cyclosporin A decreases expression ISO RGD:10143 6480464 Cyclosporine results in decreased expression of ALDOC mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:69125 6480464 Cyclosporine results in decreased expression of ALDOC mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression ISO RGD:69125 6480464 decabromobiphenyl ether results in decreased expression of ALDOC protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:69125 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALDOC mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:10143 6480464 Dexamethasone results in decreased expression of ALDOA protein CTD PMID:33567340 dextran sulfate decreases expression ISO RGD:10143 6480464 Dextran Sulfate results in decreased expression of ALDOA protein, Dextran Sulfate results in decreased expression of ALDOC mRNA CTD PMID:35093514 , PMID:35999755 diarsenic trioxide multiple interactions ISO RGD:69125 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDOC protein] CTD PMID:26598702 diarsenic trioxide decreases expression ISO RGD:69125 6480464 Arsenic Trioxide results in decreased expression of ALDOC mRNA CTD PMID:15725085 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ALDOC mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:10143 6480464 Dibutyl Phthalate results in decreased expression of ALDOA mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of ALDOC mRNA CTD PMID:18636392 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of ALDOC mRNA CTD PMID:30723492 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO RGD:10143 6480464 Diethylstilbestrol results in increased expression of ALDOA mRNA CTD PMID:15289156 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 dimethylarsinic acid multiple interactions ISO RGD:10143 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 dinophysistoxin 1 increases expression ISO RGD:69125 6480464 dinophysistoxin 1 results in increased expression of ALDOC mRNA CTD PMID:28939011 dioxygen affects expression ISO RGD:10143 6480464 Oxygen deficiency affects the expression of ALDOC mRNA CTD PMID:17193925 dioxygen increases expression ISO RGD:69125 6480464 Oxygen deficiency results in increased expression of ALDOC mRNA CTD PMID:19502547 more ... dioxygen increases expression ISO RGD:10143 6480464 Oxygen deficiency results in increased expression of ALDOA mRNA, Oxygen deficiency results in increased expression of ALDOC mRNA CTD PMID:20880076 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:69125 6480464 Antimony Potassium Tartrate results in increased expression of ALDOC mRNA CTD PMID:28713220 dizocilpine maleate increases expression EXP 6480464 Dizocilpine Maleate results in increased expression of ALDOC protein CTD PMID:21297352 dorsomorphin multiple interactions ISO RGD:69125 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:69125 6480464 Doxorubicin affects the expression of ALDOC mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:10143 6480464 [Docetaxel co-treated with Doxorubicin] results in decreased expression of ALDOA protein CTD PMID:20457137 doxorubicin decreases expression ISO RGD:69125 6480464 Doxorubicin results in decreased expression of ALDOC mRNA CTD PMID:30031762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ALDOC mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:10143 6480464 epoxiconazole results in decreased expression of ALDOA mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:69125 6480464 Ethanol results in decreased expression of ALDOC mRNA CTD PMID:23378141 ethanol affects splicing ISO RGD:10143 6480464 Ethanol affects the splicing of ALDOA mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:10143 6480464 Ethanol affects the expression of and affects the splicing of ALDOC mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:10143 6480464 Ethanol results in increased expression of ALDOA mRNA, Ethanol results in increased expression of ALDOC mRNA CTD PMID:15513904 , PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:69125 6480464 Ethyl Methanesulfonate results in decreased expression of ALDOC mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:69125 6480464 ALDOC protein affects the susceptibility to Etoposide CTD PMID:16217747 etoposide multiple interactions ISO RGD:10143 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 fenthion increases expression ISO RGD:10143 6480464 Fenthion results in increased expression of ALDOC mRNA CTD PMID:34813904 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of ALDOC mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ALDOC mRNA CTD PMID:21525395 flutamide increases expression ISO RGD:10143 6480464 Flutamide results in increased expression of ALDOA mRNA CTD PMID:17702527 folpet increases expression ISO RGD:10143 6480464 folpet results in increased expression of ALDOA mRNA, folpet results in increased expression of ALDOC mRNA CTD PMID:31558096 fumonisin B1 increases expression ISO RGD:10143 6480464 fumonisin B1 results in increased expression of ALDOA mRNA CTD PMID:16221962 furan increases expression EXP 6480464 furan results in increased expression of ALDOC mRNA CTD PMID:25539665 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALDOC mRNA CTD PMID:21782745 genistein increases expression ISO RGD:10143 6480464 Genistein results in increased expression of ALDOA mRNA CTD PMID:15289156 genistein decreases expression ISO RGD:10143 6480464 Genistein results in decreased expression of ALDOC mRNA CTD PMID:32186404 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of ALDOC mRNA CTD PMID:15860345 hydroxyurea multiple interactions ISO RGD:10143 6480464 Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein] CTD PMID:20889679 indometacin multiple interactions ISO RGD:69125 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALDOC mRNA CTD PMID:28628672 iron atom decreases expression ISO RGD:69125 6480464 Iron deficiency results in decreased expression of ALDOC mRNA CTD PMID:20368581 iron(0) decreases expression ISO RGD:69125 6480464 Iron deficiency results in decreased expression of ALDOC mRNA CTD PMID:20368581 isobutanol multiple interactions ISO RGD:69125 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDOC mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:69125 6480464 Ivermectin results in decreased expression of ALDOC protein CTD PMID:32959892 ketamine increases expression EXP 6480464 Ketamine results in increased expression of ALDOC mRNA CTD PMID:20080153 lead diacetate decreases expression ISO RGD:10143 6480464 lead acetate results in decreased expression of ALDOC protein CTD PMID:20797405 lead diacetate increases expression ISO RGD:10143 6480464 lead acetate results in increased expression of ALDOA protein CTD PMID:20797405 maneb multiple interactions ISO RGD:10143 6480464 [Paraquat co-treated with Maneb] results in decreased expression of ALDOC mRNA CTD PMID:18386188 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ALDOC mRNA CTD PMID:28801915 methamphetamine multiple interactions EXP 6480464 2 more ... CTD PMID:18299792 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ALDOC protein CTD PMID:19826936 methamphetamine affects localization EXP 6480464 Methamphetamine affects the localization of ALDOC mRNA CTD PMID:18299792 methidathion increases expression ISO RGD:10143 6480464 methidathion results in increased expression of ALDOC mRNA CTD PMID:34813904 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALDOC mRNA CTD PMID:21782745 methyl methanesulfonate decreases expression ISO RGD:69125 6480464 Methyl Methanesulfonate results in decreased expression of ALDOC mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:10143 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 mifepristone decreases expression ISO RGD:69125 6480464 Mifepristone results in decreased expression of ALDOC mRNA CTD PMID:17584828 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ALDOC mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium decreases expression ISO RGD:10143 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ALDOA mRNA CTD PMID:17475336 nickel atom decreases expression ISO RGD:69125 6480464 Nickel results in decreased expression of ALDOC mRNA CTD PMID:25583101 nickel dichloride multiple interactions ISO RGD:10143 6480464 HIF1A affects the reaction [nickel chloride results in increased expression of ALDOA mRNA] CTD PMID:12426141 nickel dichloride increases expression ISO RGD:10143 6480464 nickel chloride results in increased expression of ALDOA mRNA CTD PMID:12426141 , PMID:12839937 nickel sulfate increases expression ISO RGD:69125 6480464 nickel sulfate results in increased expression of ALDOC mRNA CTD PMID:17382205 , PMID:22714537 niclosamide decreases expression ISO RGD:69125 6480464 Niclosamide results in decreased expression of ALDOC mRNA CTD PMID:22576131 obeticholic acid increases expression ISO RGD:69125 6480464 obeticholic acid results in increased expression of ALDOC mRNA CTD PMID:27939613 oxaliplatin decreases expression ISO RGD:69125 6480464 oxaliplatin results in decreased expression of ALDOC mRNA CTD PMID:17762391 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of ALDOC mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:10143 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALDOC mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALDOC mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO RGD:69125 6480464 p-Chloromercuribenzoic Acid results in decreased expression of ALDOC mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:69125 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALDOC mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:10143 6480464 Acetaminophen affects the expression of ALDOA mRNA, Acetaminophen affects the expression of ALDOC mRNA CTD PMID:17562736 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ALDOC mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:69125 6480464 Acetaminophen results in decreased expression of ALDOC mRNA CTD PMID:29067470 paraquat multiple interactions ISO RGD:10143 6480464 [Paraquat co-treated with Maneb] results in decreased expression of ALDOC mRNA CTD PMID:18386188 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ALDOC mRNA CTD PMID:32680482 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol increases expression ISO RGD:10143 6480464 Pentachlorophenol results in increased expression of ALDOA mRNA CTD PMID:23892564 perfluorobutyric acid increases expression ISO RGD:10143 6480464 perfluorobutyric acid results in increased expression of ALDOA mRNA CTD PMID:34474067 perfluorononanoic acid decreases expression ISO RGD:69125 6480464 perfluoro-n-nonanoic acid results in decreased expression of ALDOC mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:10143 6480464 Phenobarbital affects the expression of ALDOA mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:69125 6480464 Phenylmercuric Acetate results in decreased expression of ALDOC mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:69125 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALDOC mRNA CTD PMID:27188386 phenylpropanolamine decreases expression ISO RGD:10143 6480464 Phenylpropanolamine results in decreased expression of ALDOA mRNA CTD PMID:16465460 picoxystrobin increases expression ISO RGD:69125 6480464 picoxystrobin results in increased expression of ALDOC mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:10143 6480464 pirinixic acid results in increased expression of ALDOA mRNA, pirinixic acid results in increased expression of ALDOC mRNA CTD PMID:16221962 more ... potassium chromate increases expression ISO RGD:69125 6480464 potassium chromate(VI) results in increased expression of ALDOC mRNA CTD PMID:22714537 progesterone decreases expression ISO RGD:10143 6480464 Progesterone results in decreased expression of ALDOC mRNA CTD PMID:22238285 propiconazole increases expression ISO RGD:10143 6480464 propiconazole results in increased expression of ALDOA mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:69125 6480464 Quercetin results in decreased expression of ALDOC mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:69125 6480464 resveratrol results in increased expression of ALDOC mRNA CTD PMID:15582268 resveratrol decreases expression ISO RGD:10143 6480464 Resveratrol results in decreased expression of ALDOA protein CTD PMID:25505154 rotenone increases expression ISO RGD:69125 6480464 Rotenone results in increased expression of ALDOC mRNA CTD PMID:29955902 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ALDOC protein CTD PMID:35544339 sarin affects expression EXP 6480464 Sarin affects the expression of ALDOC protein CTD PMID:28973502 SB 431542 multiple interactions ISO RGD:69125 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide affects expression ISO RGD:69125 6480464 Silicon Dioxide analog affects the expression of ALDOC mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:10143 6480464 Silver results in decreased expression of ALDOC mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:10143 6480464 Silver results in decreased expression of ALDOC mRNA CTD PMID:27131904 SKF 38393 multiple interactions EXP 6480464 2 more ... CTD PMID:18299792 sodium arsenate multiple interactions ISO RGD:10143 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:69125 6480464 sodium arsenite results in increased expression of ALDOC mRNA CTD PMID:23648393 more ... sodium arsenite multiple interactions ISO RGD:10143 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ALDOC protein CTD PMID:29459688 sodium dichromate increases expression ISO RGD:10143 6480464 sodium bichromate results in increased expression of ALDOA mRNA, sodium bichromate results in increased expression of ALDOC mRNA CTD PMID:31558096 sodium fluoride decreases expression ISO RGD:10143 6480464 Sodium Fluoride results in decreased expression of ALDOA mRNA CTD PMID:21340527 Soman decreases expression EXP 6480464 Soman results in decreased expression of ALDOC mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:69125 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALDOC mRNA CTD PMID:36139627 sulindac sulfide decreases expression ISO RGD:69125 6480464 sulindac sulfide results in decreased expression of ALDOC mRNA CTD PMID:16184548 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of ALDOC mRNA CTD PMID:26141394 tamoxifen increases expression ISO RGD:10143 6480464 Tamoxifen results in increased expression of ALDOA mRNA CTD PMID:19400957 tapentadol increases expression ISO RGD:69125 6480464 tapentadol results in increased expression of ALDOC mRNA CTD PMID:27317026 tert-butyl hydroperoxide increases expression ISO RGD:10143 6480464 tert-Butylhydroperoxide results in increased expression of ALDOA mRNA CTD PMID:15003993 testosterone multiple interactions ISO RGD:10143 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:10143 6480464 Testosterone deficiency results in increased expression of ALDOC mRNA CTD PMID:33848595 tetrachloromethane decreases expression ISO RGD:10143 6480464 Carbon Tetrachloride results in decreased expression of ALDOC mRNA CTD PMID:31919559 tetrachloromethane increases expression ISO RGD:10143 6480464 Carbon Tetrachloride results in increased expression of ALDOA mRNA CTD PMID:31919559 thapsigargin decreases expression ISO RGD:69125 6480464 Thapsigargin results in decreased expression of ALDOC mRNA CTD PMID:22378314 theophylline decreases expression ISO RGD:69125 6480464 Theophylline results in decreased expression of ALDOC mRNA CTD PMID:16083514 thimerosal decreases expression ISO RGD:69125 6480464 Thimerosal results in decreased expression of ALDOC mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ALDOC mRNA CTD PMID:23411599 trametinib multiple interactions ISO RGD:69125 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALDOC mRNA CTD PMID:36139627 triclosan decreases expression ISO RGD:69125 6480464 Triclosan results in decreased expression of ALDOC mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:10143 6480464 trimellitic anhydride results in increased expression of ALDOC mRNA CTD PMID:19042947 Triptolide decreases expression ISO RGD:10143 6480464 triptolide results in decreased expression of ALDOC mRNA CTD PMID:32835833 tunicamycin decreases expression ISO RGD:69125 6480464 Tunicamycin results in decreased expression of ALDOC mRNA CTD PMID:22378314 tunicamycin increases expression ISO RGD:69125 6480464 Tunicamycin results in increased expression of ALDOC mRNA CTD PMID:29453283 valproic acid decreases methylation ISO RGD:69125 6480464 Valproic Acid results in decreased methylation of ALDOC gene CTD PMID:29154799 valproic acid affects expression ISO RGD:69125 6480464 Valproic Acid affects the expression of ALDOC mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:69125 6480464 Valproic Acid results in decreased expression of ALDOC mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:10143 6480464 Valproic Acid affects the expression of ALDOA mRNA, Valproic Acid affects the expression of ALDOC mRNA CTD PMID:17963808 vancomycin increases expression ISO RGD:10143 6480464 Vancomycin results in increased expression of ALDOC mRNA CTD PMID:18930951 vincristine decreases expression ISO RGD:69125 6480464 Vincristine results in decreased expression of ALDOC mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:69125 6480464 vorinostat results in decreased expression of ALDOC mRNA CTD PMID:27188386 Yessotoxin increases expression ISO RGD:69125 6480464 yessotoxin analog results in increased expression of ALDOC mRNA CTD PMID:30679557 yohimbine multiple interactions ISO RGD:10143 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 zearalenone decreases expression ISO RGD:10143 6480464 Zearalenone results in decreased expression of ALDOC protein CTD PMID:25058043 zinc dichloride multiple interactions ISO RGD:69125 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] CTD PMID:22202117